0001193125-18-132607.txt : 20181219 0001193125-18-132607.hdr.sgml : 20181219 20180426060755 ACCESSION NUMBER: 0001193125-18-132607 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20180426 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Taiwan Liposome Company, Ltd. CENTRAL INDEX KEY: 0001722890 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: F5 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 2F, 3 YUANQU STREET STREET 2: NANGANG DISTRICT CITY: TAIPEI CITY STATE: F5 ZIP: 11503 BUSINESS PHONE: 886 2 2655 7377 MAIL ADDRESS: STREET 1: 2F, 3 YUANQU STREET STREET 2: NANGANG DISTRICT CITY: TAIPEI CITY STATE: F5 ZIP: 11503 CORRESP 1 filename1.htm CORRESP

April 26, 2018

U.S. Securities and Exchange Commission    

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549-3628

Attn: Jeff Gabor

 

Re: Taiwan Liposome Company, Ltd.
  Registration Statement on Form F-1, as amended
  File No. 333-223090
  Withdrawal of Acceleration Request

Ladies and Gentlemen:

Reference is made to our letter, filed as correspondence via EDGAR on April 23, 2018, in which we requested the acceleration of the effective date of the above-referenced registration statement for Wednesday, April 25, 2018, at 4:00 p.m. Eastern Time, or as soon thereafter as possible, in accordance with Rule 461 under the Securities Act of 1933, as amended. We are no longer requesting that such registration statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.

 

Very truly yours,
Taiwan Liposome Company, Ltd.
By:  

/s/ George Yeh

  George Yeh
  President